Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma

clinical trial

Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT00006024

P6099clinical trial phasephase I clinical trialQ5452194
P17countryUnited States of AmericaQ30
SwitzerlandQ39
NetherlandsQ55
CanadaQ16
New ZealandQ664
AustraliaQ408
P582end time2005-01-01
P131located in the administrative territorial entityPuerto RicoQ1183
P4135maximum age21
P2899minimum age3
P1132number of participants32
P6153research siteVanderbilt UniversityQ29052
New York UniversityQ49210
Cedars-Sinai Medical CenterQ1052562
Loma Linda UniversityQ1057447
Michigan State UniversityQ270222
University of California, San FranciscoQ1061104
Dana–Farber Cancer InstituteQ1159198
Tulane UniversityQ1193547
New York Medical CollegeQ4115972
Children's Hospital of PhiladelphiaQ4569202
Baystate Medical CenterQ4874851
Children's Hospital of MichiganQ5098127
Children's Hospital of Orange CountyQ5098129
UPMC Children's Hospital of PittsburghQ5098130
Children's Hospital of The King's DaughtersQ5098131
Children's National HospitalQ5098193
Cross Cancer InstituteQ5188247
Dartmouth UniversityQ5225736
East Tennessee Children's HospitalQ5329496
Eastern Maine Medical CenterQ5330270
Faculté de droit de l'Université LavalQ5429093
Group Health CooperativeQ5611154
Long Island Jewish Medical CenterQ6672700
Maimonides Medical CenterQ6735870
Atrium Health Navicent The Medical CenterQ6806287
Medical University of South CarolinaQ6806451
Newark Beth Israel Medical CenterQ7016630
Oregon Health & Science UniversityQ282097
Southern Illinois University EdwardsvilleQ519349
University at BuffaloQ681025
East Carolina UniversityQ1277776
Fred Hutchinson Cancer Research CenterQ1452369
Kaiser PermanenteQ1721601
Memorial Sloan Kettering Cancer CenterQ1808012
Hurley Medical CenterQ14716149
IWK Health CentreQ14875689
Atlantic Health SystemQ16975669
Carolinas Medical CenterQ17514683
Phoenix Children's HospitalQ18156816
University of Iowa Health CareQ30254145
Cook Children's Medical CenterQ30254344
Children's Hospital of OklahomaQ30265254
AdventHealth Cancer InstituteQ30280268
CancerCare ManitobaQ30282110
Nemours Children's ClinicQ30287258
University of Connecticut Avery PointQ33526665
Chao Family Comprehensive Cancer CenterQ45137223
Children's Hospitals and Clinics of MinnesotaQ50497514
University of Utah Health CareQ56582915
Princess Margaret Hospital for ChildrenQ7244698
Rhode Island HospitalQ7320925
Roswell Park Comprehensive Cancer CenterQ7370121
Royal Children's HospitalQ7373942
Santa Barbara Cottage HospitalQ7419217
St. Joseph's Hospital and Medical CenterQ7589191
University of Mississippi Medical CenterQ7895818
University of Nebraska Medical CenterQ7895888
Wesley Medical CenterQ7983961
University of South AlabamaQ13572981
Saint Louis UniversityQ734774
Washington University in St. LouisQ777403
Case Western Reserve UniversityQ1047060
Icahn School of Medicine at Mount SinaiQ1950740
University Medical Center GroningenQ2057113
Virginia Commonwealth UniversityQ2303536
Alberta Children's HospitalQ2831698
Baylor College of MedicineQ2892284
Children's Hospital of Eastern OntarioQ2945735
Centre hospitalier universitaire Sainte-JustineQ2945760
St. Mary's HospitalQ3495342
P580start time2000-11-01
P8363study typeinterventional studyQ78089383
P1476titleA Phase I Study of Temozolomide and CCNU in Pediatric Patients With Newly Diagnosed Incompletely Resected Non-Brainstem High-Grade Gliomas